Why the study?
There is limited evidence on the efficacy of cardio-oncology rehabilitation and exercise programmes, alongside an urgent need to reinforce evidence informing cardiovascular care of cancer survivors.
This whitepaper provides a roadmap and research standards to improve the evidence base for cardio-oncology rehabilitation and exercise programs.
Answers are grounded in this paper and cite their sources.
Provides scalable CORE model for CV health in cancer survivors; extends cardiac rehab frameworks by setting standards to address evidence gaps.
The aim of this whitepaper is to review the current state of the literature on the effects of cardio-oncology rehabilitation and exercise (CORE) programmes and provide a roadmap for improving the evidence-based to support the implementation of CORE. There is an urgent need to reinforce and extend the evidence informing the cardiovascular care of cancer survivors. CORE is an attractive model that is potentially scalable to improve the cardiovascular health of cancer survivors as it leverages many of the existing frameworks developed through decades of delivery of cardiac rehabilitation. However, there are several challenges within this burgeoning field, including limited evidence of the efficacy of this approach in patients with cancer. In this paper, a multidisciplinary team of international experts highlights priorities for future research in this field and recommends standards for the conduct of research.
No takes yet. Share an insight, caveat, or question.
Adams et al. (2025) conducted a review in Cancer survivors. Cardio-oncology rehabilitation and exercise (CORE) was evaluated. Cardio-oncology rehabilitation and exercise (CORE) is a potentially scalable model to improve cardiovascular health in cancer survivors, though current evidence of its efficacy remains limited.
Synapse has enriched 10 related papers. Consider them for comparative context: